drug
as of 2026-07-01OLZ/SAM
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Alkermes, Inc.
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
2
Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects
NCT04987229Phase 3Enrolling By Invitation
KOLs & investigators
1
David McDonnell, MDKOL score 8
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here